"Classification of Unscheduled Peptides
Amycretin (also known as zenagamtide, development code NN9487) is a novel, first-in-class, unimolecular dual agonist that simultaneously activates two receptor systems: GLP-1 receptors and amylin receptors
Designed strictly for research, the kit allows controlled investigation into solution stability, dispersion, and experimental outcomes
Peripheral trigeminal nerve blocks and deeper image-guided injections may cause temporary facial numbness, weakness of nearby muscles, bruising, bleeding, infection, temporary pain flare, nerve irritation, vascular puncture, intravascular injection, local-anesthetic toxicity, or injury to nearby structures
Direct impact can shear peptide bonds through mechanical force, damaging the compound before it even dissolves
Xi'an Sonwu ensures product quality and can provide samples